nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—ABCB1—Mitomycin—urinary bladder cancer	0.155	0.258	CbGbCtD
Prednisolone—CYP2A6—Fluorouracil—urinary bladder cancer	0.115	0.19	CbGbCtD
Prednisolone—SLCO1A2—Methotrexate—urinary bladder cancer	0.078	0.129	CbGbCtD
Prednisolone—CYP3A4—Thiotepa—urinary bladder cancer	0.0705	0.117	CbGbCtD
Prednisolone—ABCB1—Gemcitabine—urinary bladder cancer	0.0447	0.0742	CbGbCtD
Prednisolone—ABCB1—Cisplatin—urinary bladder cancer	0.0325	0.0539	CbGbCtD
Prednisolone—ABCB1—Etoposide—urinary bladder cancer	0.0319	0.053	CbGbCtD
Prednisolone—ABCB1—Doxorubicin—urinary bladder cancer	0.0218	0.0361	CbGbCtD
Prednisolone—ABCB1—Methotrexate—urinary bladder cancer	0.0211	0.035	CbGbCtD
Prednisolone—CYP3A4—Etoposide—urinary bladder cancer	0.0191	0.0317	CbGbCtD
Prednisolone—CYP3A4—Doxorubicin—urinary bladder cancer	0.013	0.0216	CbGbCtD
Prednisolone—NR3C1—urine—urinary bladder cancer	0.00622	0.0844	CbGeAlD
Prednisolone—CYP3A4—urine—urinary bladder cancer	0.0047	0.0638	CbGeAlD
Prednisolone—CYP2A6—prostate gland—urinary bladder cancer	0.00444	0.0602	CbGeAlD
Prednisolone—NR3C2—prostate gland—urinary bladder cancer	0.00416	0.0565	CbGeAlD
Prednisolone—CYP2A6—seminal vesicle—urinary bladder cancer	0.00376	0.051	CbGeAlD
Prednisolone—NR3C2—seminal vesicle—urinary bladder cancer	0.00352	0.0478	CbGeAlD
Prednisolone—SERPINA6—renal system—urinary bladder cancer	0.00347	0.0471	CbGeAlD
Prednisolone—NR3C2—smooth muscle tissue—urinary bladder cancer	0.00295	0.04	CbGeAlD
Prednisolone—NR3C2—renal system—urinary bladder cancer	0.00284	0.0385	CbGeAlD
Prednisolone—NR3C2—urethra—urinary bladder cancer	0.00279	0.0378	CbGeAlD
Prednisolone—SERPINA6—female reproductive system—urinary bladder cancer	0.00278	0.0378	CbGeAlD
Prednisolone—SLCO1A2—renal system—urinary bladder cancer	0.00243	0.033	CbGeAlD
Prednisolone—NR3C2—female reproductive system—urinary bladder cancer	0.00227	0.0308	CbGeAlD
Prednisolone—NR3C1—prostate gland—urinary bladder cancer	0.00223	0.0303	CbGeAlD
Prednisolone—CYP2A6—vagina—urinary bladder cancer	0.00219	0.0297	CbGeAlD
Prednisolone—NR3C2—vagina—urinary bladder cancer	0.00205	0.0279	CbGeAlD
Prednisolone—NR3C1—seminal vesicle—urinary bladder cancer	0.00189	0.0256	CbGeAlD
Prednisolone—NR3C1—epithelium—urinary bladder cancer	0.00164	0.0223	CbGeAlD
Prednisolone—NR3C1—smooth muscle tissue—urinary bladder cancer	0.00158	0.0214	CbGeAlD
Prednisolone—NR3C1—renal system—urinary bladder cancer	0.00152	0.0206	CbGeAlD
Prednisolone—NR3C1—urethra—urinary bladder cancer	0.00149	0.0203	CbGeAlD
Prednisolone—NR3C2—lymph node—urinary bladder cancer	0.00133	0.018	CbGeAlD
Prednisolone—NR3C1—female reproductive system—urinary bladder cancer	0.00122	0.0165	CbGeAlD
Prednisolone—ABCB1—prostate gland—urinary bladder cancer	0.0012	0.0162	CbGeAlD
Prednisolone—CYP3A4—renal system—urinary bladder cancer	0.00115	0.0156	CbGeAlD
Prednisolone—NR3C1—vagina—urinary bladder cancer	0.0011	0.015	CbGeAlD
Prednisolone—ABCB1—seminal vesicle—urinary bladder cancer	0.00101	0.0137	CbGeAlD
Prednisolone—CYP3A4—female reproductive system—urinary bladder cancer	0.000922	0.0125	CbGeAlD
Prednisolone—ABCB1—epithelium—urinary bladder cancer	0.000878	0.0119	CbGeAlD
Prednisolone—ABCB1—renal system—urinary bladder cancer	0.000815	0.0111	CbGeAlD
Prednisolone—ABCB1—urethra—urinary bladder cancer	0.0008	0.0109	CbGeAlD
Prednisolone—NR3C1—lymph node—urinary bladder cancer	0.000713	0.00967	CbGeAlD
Prednisolone—ABCB1—female reproductive system—urinary bladder cancer	0.000652	0.00885	CbGeAlD
Prednisolone—Headache—Mitomycin—urinary bladder cancer	0.000628	0.00255	CcSEcCtD
Prednisolone—Arthropathy—Epirubicin—urinary bladder cancer	0.000626	0.00254	CcSEcCtD
Prednisolone—Vasculitis—Methotrexate—urinary bladder cancer	0.000623	0.00253	CcSEcCtD
Prednisolone—Sweating increased—Etoposide—urinary bladder cancer	0.00062	0.00252	CcSEcCtD
Prednisolone—Erythema—Thiotepa—urinary bladder cancer	0.000618	0.00251	CcSEcCtD
Prednisolone—Herpes simplex—Epirubicin—urinary bladder cancer	0.000617	0.0025	CcSEcCtD
Prednisolone—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.000611	0.00248	CcSEcCtD
Prednisolone—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.000608	0.00246	CcSEcCtD
Prednisolone—Myocardial infarction—Cisplatin—urinary bladder cancer	0.000608	0.00246	CcSEcCtD
Prednisolone—Conjunctivitis—Cisplatin—urinary bladder cancer	0.000603	0.00244	CcSEcCtD
Prednisolone—Haemoglobin—Gemcitabine—urinary bladder cancer	0.0006	0.00243	CcSEcCtD
Prednisolone—Haemorrhage—Gemcitabine—urinary bladder cancer	0.000597	0.00242	CcSEcCtD
Prednisolone—Nausea—Mitomycin—urinary bladder cancer	0.000596	0.00242	CcSEcCtD
Prednisolone—ABCB1—vagina—urinary bladder cancer	0.00059	0.00801	CbGeAlD
Prednisolone—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00059	0.00239	CcSEcCtD
Prednisolone—Haemorrhage—Fluorouracil—urinary bladder cancer	0.000587	0.00238	CcSEcCtD
Prednisolone—Viral infection—Doxorubicin—urinary bladder cancer	0.000583	0.00236	CcSEcCtD
Prednisolone—Vision blurred—Thiotepa—urinary bladder cancer	0.000582	0.00236	CcSEcCtD
Prednisolone—Arthropathy—Doxorubicin—urinary bladder cancer	0.000579	0.00235	CcSEcCtD
Prednisolone—Herpes simplex—Doxorubicin—urinary bladder cancer	0.000571	0.00232	CcSEcCtD
Prednisolone—Hiccups—Epirubicin—urinary bladder cancer	0.000569	0.00231	CcSEcCtD
Prednisolone—Bradycardia—Cisplatin—urinary bladder cancer	0.000566	0.0023	CcSEcCtD
Prednisolone—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.00056	0.00227	CcSEcCtD
Prednisolone—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.000557	0.00226	CcSEcCtD
Prednisolone—Myocardial infarction—Etoposide—urinary bladder cancer	0.000557	0.00226	CcSEcCtD
Prednisolone—Ecchymosis—Methotrexate—urinary bladder cancer	0.00055	0.00223	CcSEcCtD
Prednisolone—Pulmonary oedema—Methotrexate—urinary bladder cancer	0.000541	0.0022	CcSEcCtD
Prednisolone—Fluid retention—Epirubicin—urinary bladder cancer	0.00054	0.00219	CcSEcCtD
Prednisolone—Visual impairment—Cisplatin—urinary bladder cancer	0.000536	0.00218	CcSEcCtD
Prednisolone—Convulsion—Thiotepa—urinary bladder cancer	0.000535	0.00217	CcSEcCtD
Prednisolone—Neuropathy—Epirubicin—urinary bladder cancer	0.000534	0.00217	CcSEcCtD
Prednisolone—Hypertension—Thiotepa—urinary bladder cancer	0.000533	0.00216	CcSEcCtD
Prednisolone—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000533	0.00216	CcSEcCtD
Prednisolone—Hiccups—Doxorubicin—urinary bladder cancer	0.000527	0.00214	CcSEcCtD
Prednisolone—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000524	0.00213	CcSEcCtD
Prednisolone—Erythema—Gemcitabine—urinary bladder cancer	0.00052	0.00211	CcSEcCtD
Prednisolone—Ecchymosis—Epirubicin—urinary bladder cancer	0.000514	0.00209	CcSEcCtD
Prednisolone—Erythema—Fluorouracil—urinary bladder cancer	0.000511	0.00207	CcSEcCtD
Prednisolone—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.00051	0.00207	CcSEcCtD
Prednisolone—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.000507	0.00206	CcSEcCtD
Prednisolone—Pulmonary oedema—Epirubicin—urinary bladder cancer	0.000506	0.00205	CcSEcCtD
Prednisolone—Fluid retention—Doxorubicin—urinary bladder cancer	0.0005	0.00203	CcSEcCtD
Prednisolone—Arrhythmia—Cisplatin—urinary bladder cancer	0.000497	0.00202	CcSEcCtD
Prednisolone—Neuropathy—Doxorubicin—urinary bladder cancer	0.000494	0.00201	CcSEcCtD
Prednisolone—Tachycardia—Thiotepa—urinary bladder cancer	0.000492	0.002	CcSEcCtD
Prednisolone—Erythema—Cisplatin—urinary bladder cancer	0.000484	0.00196	CcSEcCtD
Prednisolone—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000482	0.00196	CcSEcCtD
Prednisolone—Vision blurred—Fluorouracil—urinary bladder cancer	0.000482	0.00195	CcSEcCtD
Prednisolone—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.000477	0.00194	CcSEcCtD
Prednisolone—Ecchymosis—Doxorubicin—urinary bladder cancer	0.000476	0.00193	CcSEcCtD
Prednisolone—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.000475	0.00193	CcSEcCtD
Prednisolone—Malaise—Gemcitabine—urinary bladder cancer	0.000469	0.0019	CcSEcCtD
Prednisolone—Pulmonary oedema—Doxorubicin—urinary bladder cancer	0.000469	0.0019	CcSEcCtD
Prednisolone—Visual disturbance—Methotrexate—urinary bladder cancer	0.000466	0.00189	CcSEcCtD
Prednisolone—Vision blurred—Cisplatin—urinary bladder cancer	0.000457	0.00185	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000456	0.00185	CcSEcCtD
Prednisolone—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.000455	0.00185	CcSEcCtD
Prednisolone—Paraesthesia—Thiotepa—urinary bladder cancer	0.000453	0.00184	CcSEcCtD
Prednisolone—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000449	0.00182	CcSEcCtD
Prednisolone—Hypertension—Gemcitabine—urinary bladder cancer	0.000449	0.00182	CcSEcCtD
Prednisolone—Convulsion—Fluorouracil—urinary bladder cancer	0.000443	0.0018	CcSEcCtD
Prednisolone—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.000442	0.00179	CcSEcCtD
Prednisolone—Osteoarthritis—Methotrexate—urinary bladder cancer	0.000441	0.00179	CcSEcCtD
Prednisolone—Increased appetite—Epirubicin—urinary bladder cancer	0.00044	0.00178	CcSEcCtD
Prednisolone—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.000439	0.00178	CcSEcCtD
Prednisolone—Discomfort—Gemcitabine—urinary bladder cancer	0.000437	0.00177	CcSEcCtD
Prednisolone—Malaise—Cisplatin—urinary bladder cancer	0.000437	0.00177	CcSEcCtD
Prednisolone—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.000432	0.00175	CcSEcCtD
Prednisolone—Pain—Thiotepa—urinary bladder cancer	0.000431	0.00175	CcSEcCtD
Prednisolone—Discomfort—Fluorouracil—urinary bladder cancer	0.00043	0.00174	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.000427	0.00173	CcSEcCtD
Prednisolone—Oedema—Gemcitabine—urinary bladder cancer	0.000424	0.00172	CcSEcCtD
Prednisolone—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000424	0.00172	CcSEcCtD
Prednisolone—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.000421	0.00171	CcSEcCtD
Prednisolone—Convulsion—Cisplatin—urinary bladder cancer	0.00042	0.0017	CcSEcCtD
Prednisolone—Mood swings—Methotrexate—urinary bladder cancer	0.000418	0.0017	CcSEcCtD
Prednisolone—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000417	0.00169	CcSEcCtD
Prednisolone—Oedema—Fluorouracil—urinary bladder cancer	0.000417	0.00169	CcSEcCtD
Prednisolone—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000415	0.00169	CcSEcCtD
Prednisolone—Osteoarthritis—Epirubicin—urinary bladder cancer	0.000413	0.00168	CcSEcCtD
Prednisolone—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000412	0.00167	CcSEcCtD
Prednisolone—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00041	0.00166	CcSEcCtD
Prednisolone—Discomfort—Cisplatin—urinary bladder cancer	0.000407	0.00165	CcSEcCtD
Prednisolone—Tachycardia—Fluorouracil—urinary bladder cancer	0.000407	0.00165	CcSEcCtD
Prednisolone—Increased appetite—Doxorubicin—urinary bladder cancer	0.000407	0.00165	CcSEcCtD
Prednisolone—Affect lability—Epirubicin—urinary bladder cancer	0.000407	0.00165	CcSEcCtD
Prednisolone—Urticaria—Thiotepa—urinary bladder cancer	0.000401	0.00162	CcSEcCtD
Prednisolone—Malaise—Etoposide—urinary bladder cancer	0.0004	0.00162	CcSEcCtD
Prednisolone—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.0004	0.00162	CcSEcCtD
Prednisolone—Vertigo—Etoposide—urinary bladder cancer	0.000399	0.00162	CcSEcCtD
Prednisolone—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000395	0.0016	CcSEcCtD
Prednisolone—Oedema—Cisplatin—urinary bladder cancer	0.000395	0.0016	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000395	0.0016	CcSEcCtD
Prednisolone—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000393	0.00159	CcSEcCtD
Prednisolone—Mood swings—Epirubicin—urinary bladder cancer	0.000391	0.00159	CcSEcCtD
Prednisolone—Loss of consciousness—Etoposide—urinary bladder cancer	0.00039	0.00158	CcSEcCtD
Prednisolone—Tachycardia—Cisplatin—urinary bladder cancer	0.000386	0.00157	CcSEcCtD
Prednisolone—Convulsion—Etoposide—urinary bladder cancer	0.000384	0.00156	CcSEcCtD
Prednisolone—Insomnia—Gemcitabine—urinary bladder cancer	0.000384	0.00156	CcSEcCtD
Prednisolone—Hypertension—Etoposide—urinary bladder cancer	0.000383	0.00155	CcSEcCtD
Prednisolone—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.000382	0.00155	CcSEcCtD
Prednisolone—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000382	0.00155	CcSEcCtD
Prednisolone—ABCB1—lymph node—urinary bladder cancer	0.000382	0.00518	CbGeAlD
Prednisolone—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000381	0.00154	CcSEcCtD
Prednisolone—Dry skin—Epirubicin—urinary bladder cancer	0.000379	0.00154	CcSEcCtD
Prednisolone—Insomnia—Fluorouracil—urinary bladder cancer	0.000377	0.00153	CcSEcCtD
Prednisolone—Affect lability—Doxorubicin—urinary bladder cancer	0.000376	0.00153	CcSEcCtD
Prednisolone—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000374	0.00152	CcSEcCtD
Prednisolone—Pancreatitis—Methotrexate—urinary bladder cancer	0.000374	0.00152	CcSEcCtD
Prednisolone—Discomfort—Etoposide—urinary bladder cancer	0.000373	0.00151	CcSEcCtD
Prednisolone—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000371	0.00151	CcSEcCtD
Prednisolone—Muscular weakness—Epirubicin—urinary bladder cancer	0.000364	0.00148	CcSEcCtD
Prednisolone—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000363	0.00147	CcSEcCtD
Prednisolone—Pain—Gemcitabine—urinary bladder cancer	0.000363	0.00147	CcSEcCtD
Prednisolone—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000362	0.00147	CcSEcCtD
Prednisolone—Mood swings—Doxorubicin—urinary bladder cancer	0.000362	0.00147	CcSEcCtD
Prednisolone—Abdominal distension—Epirubicin—urinary bladder cancer	0.000359	0.00146	CcSEcCtD
Prednisolone—Pain—Fluorouracil—urinary bladder cancer	0.000357	0.00145	CcSEcCtD
Prednisolone—Paraesthesia—Cisplatin—urinary bladder cancer	0.000355	0.00144	CcSEcCtD
Prednisolone—Tachycardia—Etoposide—urinary bladder cancer	0.000353	0.00143	CcSEcCtD
Prednisolone—Dry skin—Doxorubicin—urinary bladder cancer	0.00035	0.00142	CcSEcCtD
Prednisolone—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00035	0.00142	CcSEcCtD
Prednisolone—Pancreatitis—Epirubicin—urinary bladder cancer	0.00035	0.00142	CcSEcCtD
Prednisolone—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00035	0.00142	CcSEcCtD
Prednisolone—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000344	0.00139	CcSEcCtD
Prednisolone—Pain—Cisplatin—urinary bladder cancer	0.000338	0.00137	CcSEcCtD
Prednisolone—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000337	0.00137	CcSEcCtD
Prednisolone—Dizziness—Thiotepa—urinary bladder cancer	0.000333	0.00135	CcSEcCtD
Prednisolone—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000333	0.00135	CcSEcCtD
Prednisolone—Urticaria—Fluorouracil—urinary bladder cancer	0.000331	0.00134	CcSEcCtD
Prednisolone—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000331	0.00134	CcSEcCtD
Prednisolone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000326	0.00132	CcSEcCtD
Prednisolone—Paraesthesia—Etoposide—urinary bladder cancer	0.000325	0.00132	CcSEcCtD
Prednisolone—Weight increased—Epirubicin—urinary bladder cancer	0.000325	0.00132	CcSEcCtD
Prednisolone—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000324	0.00131	CcSEcCtD
Prednisolone—Rash—Thiotepa—urinary bladder cancer	0.000318	0.00129	CcSEcCtD
Prednisolone—Dermatitis—Thiotepa—urinary bladder cancer	0.000318	0.00129	CcSEcCtD
Prednisolone—Headache—Thiotepa—urinary bladder cancer	0.000316	0.00128	CcSEcCtD
Prednisolone—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000312	0.00127	CcSEcCtD
Prednisolone—Pain—Etoposide—urinary bladder cancer	0.00031	0.00126	CcSEcCtD
Prednisolone—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000309	0.00126	CcSEcCtD
Prednisolone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000307	0.00125	CcSEcCtD
Prednisolone—Haemoglobin—Methotrexate—urinary bladder cancer	0.000307	0.00124	CcSEcCtD
Prednisolone—Haemorrhage—Methotrexate—urinary bladder cancer	0.000305	0.00124	CcSEcCtD
Prednisolone—Weight increased—Doxorubicin—urinary bladder cancer	0.000301	0.00122	CcSEcCtD
Prednisolone—Nausea—Thiotepa—urinary bladder cancer	0.000299	0.00121	CcSEcCtD
Prednisolone—Feeling abnormal—Etoposide—urinary bladder cancer	0.000298	0.00121	CcSEcCtD
Prednisolone—Visual impairment—Methotrexate—urinary bladder cancer	0.000294	0.00119	CcSEcCtD
Prednisolone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000291	0.00118	CcSEcCtD
Prednisolone—Bradycardia—Epirubicin—urinary bladder cancer	0.000291	0.00118	CcSEcCtD
Prednisolone—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000289	0.00117	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.000289	0.00377	CbGpPWpGaD
Prednisolone—Urticaria—Etoposide—urinary bladder cancer	0.000288	0.00117	CcSEcCtD
Prednisolone—Haemoglobin—Epirubicin—urinary bladder cancer	0.000287	0.00117	CcSEcCtD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.000286	0.00374	CbGpPWpGaD
Prednisolone—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000286	0.00116	CcSEcCtD
Prednisolone—Haemorrhage—Epirubicin—urinary bladder cancer	0.000286	0.00116	CcSEcCtD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000285	0.00372	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000283	0.00369	CbGpPWpGaD
Prednisolone—Fluoxymesterone—ESR1—urinary bladder cancer	0.000278	0.387	CrCbGaD
Prednisolone—Dizziness—Fluorouracil—urinary bladder cancer	0.000276	0.00112	CcSEcCtD
Prednisolone—Visual impairment—Epirubicin—urinary bladder cancer	0.000275	0.00112	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—ESR1—urinary bladder cancer	0.000272	0.00354	CbGpPWpGaD
Prednisolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—urinary bladder cancer	0.00027	0.00352	CbGpPWpGaD
Prednisolone—Bradycardia—Doxorubicin—urinary bladder cancer	0.000269	0.00109	CcSEcCtD
Prednisolone—Rash—Gemcitabine—urinary bladder cancer	0.000267	0.00108	CcSEcCtD
Prednisolone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000267	0.00108	CcSEcCtD
Prednisolone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000267	0.00108	CcSEcCtD
Prednisolone—Erythema—Methotrexate—urinary bladder cancer	0.000266	0.00108	CcSEcCtD
Prednisolone—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000266	0.00108	CcSEcCtD
Prednisolone—Headache—Gemcitabine—urinary bladder cancer	0.000266	0.00108	CcSEcCtD
Prednisolone—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000264	0.00107	CcSEcCtD
Prednisolone—Rash—Fluorouracil—urinary bladder cancer	0.000263	0.00107	CcSEcCtD
Prednisolone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000263	0.00107	CcSEcCtD
Prednisolone—Headache—Fluorouracil—urinary bladder cancer	0.000261	0.00106	CcSEcCtD
Prednisolone—Arrhythmia—Epirubicin—urinary bladder cancer	0.000255	0.00104	CcSEcCtD
Prednisolone—Visual impairment—Doxorubicin—urinary bladder cancer	0.000255	0.00103	CcSEcCtD
Prednisolone—Nausea—Gemcitabine—urinary bladder cancer	0.000252	0.00102	CcSEcCtD
Prednisolone—Vision blurred—Methotrexate—urinary bladder cancer	0.000251	0.00102	CcSEcCtD
Prednisolone—Rash—Cisplatin—urinary bladder cancer	0.000249	0.00101	CcSEcCtD
Prednisolone—Dermatitis—Cisplatin—urinary bladder cancer	0.000249	0.00101	CcSEcCtD
Prednisolone—Erythema—Epirubicin—urinary bladder cancer	0.000249	0.00101	CcSEcCtD
Prednisolone—Nausea—Fluorouracil—urinary bladder cancer	0.000248	0.001	CcSEcCtD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000247	0.00322	CbGpPWpGaD
Prednisolone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000247	0.001	CcSEcCtD
Prednisolone—CYP2A6—Biological oxidations—HPGDS—urinary bladder cancer	0.000246	0.00321	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.000243	0.00317	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.000242	0.00315	CbGpPWpGaD
Prednisolone—Malaise—Methotrexate—urinary bladder cancer	0.00024	0.000972	CcSEcCtD
Prednisolone—Dizziness—Etoposide—urinary bladder cancer	0.000239	0.000971	CcSEcCtD
Prednisolone—Vertigo—Methotrexate—urinary bladder cancer	0.000239	0.000969	CcSEcCtD
Prednisolone—CYP2A6—Biological oxidations—GSTT1—urinary bladder cancer	0.000239	0.00312	CbGpPWpGaD
Prednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000237	0.0031	CbGpPWpGaD
Prednisolone—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000236	0.000958	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000236	0.00308	CbGpPWpGaD
Prednisolone—Nausea—Cisplatin—urinary bladder cancer	0.000235	0.000953	CcSEcCtD
Prednisolone—Vision blurred—Epirubicin—urinary bladder cancer	0.000234	0.000951	CcSEcCtD
Prednisolone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000231	0.000936	CcSEcCtD
Prednisolone—Convulsion—Methotrexate—urinary bladder cancer	0.00023	0.000934	CcSEcCtD
Prednisolone—Erythema—Doxorubicin—urinary bladder cancer	0.00023	0.000934	CcSEcCtD
Prednisolone—Rash—Etoposide—urinary bladder cancer	0.000228	0.000926	CcSEcCtD
Prednisolone—Dermatitis—Etoposide—urinary bladder cancer	0.000228	0.000925	CcSEcCtD
Prednisolone—Headache—Etoposide—urinary bladder cancer	0.000227	0.00092	CcSEcCtD
Prednisolone—CYP2A6—NRF2 pathway—NQO1—urinary bladder cancer	0.000226	0.00295	CbGpPWpGaD
Prednisolone—Malaise—Epirubicin—urinary bladder cancer	0.000224	0.00091	CcSEcCtD
Prednisolone—Discomfort—Methotrexate—urinary bladder cancer	0.000224	0.000907	CcSEcCtD
Prednisolone—Vertigo—Epirubicin—urinary bladder cancer	0.000223	0.000907	CcSEcCtD
Prednisolone—Syncope—Epirubicin—urinary bladder cancer	0.000223	0.000905	CcSEcCtD
Prednisolone—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000219	0.000887	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000219	0.00285	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000217	0.00284	CbGpPWpGaD
Prednisolone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000217	0.00088	CcSEcCtD
Prednisolone—Vision blurred—Doxorubicin—urinary bladder cancer	0.000217	0.00088	CcSEcCtD
Prednisolone—Convulsion—Epirubicin—urinary bladder cancer	0.000216	0.000874	CcSEcCtD
Prednisolone—Nausea—Etoposide—urinary bladder cancer	0.000215	0.000873	CcSEcCtD
Prednisolone—Hypertension—Epirubicin—urinary bladder cancer	0.000215	0.000871	CcSEcCtD
Prednisolone—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000214	0.0028	CbGpPWpGaD
Prednisolone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000214	0.000866	CcSEcCtD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000212	0.00276	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—NCOR1—urinary bladder cancer	0.000211	0.00275	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—urinary bladder cancer	0.00021	0.00274	CbGpPWpGaD
Prednisolone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00021	0.000851	CcSEcCtD
Prednisolone—Discomfort—Epirubicin—urinary bladder cancer	0.000209	0.000849	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.000208	0.00272	CbGpPWpGaD
Prednisolone—Malaise—Doxorubicin—urinary bladder cancer	0.000208	0.000842	CcSEcCtD
Prednisolone—Vertigo—Doxorubicin—urinary bladder cancer	0.000207	0.000839	CcSEcCtD
Prednisolone—Syncope—Doxorubicin—urinary bladder cancer	0.000206	0.000837	CcSEcCtD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000206	0.00269	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000206	0.00269	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000206	0.00269	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000203	0.00265	CbGpPWpGaD
Prednisolone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000203	0.000824	CcSEcCtD
Prednisolone—Oedema—Epirubicin—urinary bladder cancer	0.000203	0.000824	CcSEcCtD
Prednisolone—NR3C1—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.000203	0.00264	CbGpPWpGaD
Prednisolone—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000202	0.000821	CcSEcCtD
Prednisolone—Shock—Epirubicin—urinary bladder cancer	0.0002	0.00081	CcSEcCtD
Prednisolone—Convulsion—Doxorubicin—urinary bladder cancer	0.000199	0.000809	CcSEcCtD
Prednisolone—Hypertension—Doxorubicin—urinary bladder cancer	0.000199	0.000806	CcSEcCtD
Prednisolone—Tachycardia—Epirubicin—urinary bladder cancer	0.000198	0.000804	CcSEcCtD
Prednisolone—NR3C1—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.000197	0.00257	CbGpPWpGaD
Prednisolone—NR3C1—Circadian Clock—EP300—urinary bladder cancer	0.000197	0.00257	CbGpPWpGaD
Prednisolone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000196	0.000796	CcSEcCtD
Prednisolone—Insomnia—Methotrexate—urinary bladder cancer	0.000196	0.000796	CcSEcCtD
Prednisolone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000195	0.00079	CcSEcCtD
Prednisolone—Discomfort—Doxorubicin—urinary bladder cancer	0.000194	0.000785	CcSEcCtD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000191	0.00249	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000189	0.00247	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—FAS—urinary bladder cancer	0.000189	0.00247	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—GSTP1—urinary bladder cancer	0.000189	0.00246	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000188	0.00246	CbGpPWpGaD
Prednisolone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000188	0.000762	CcSEcCtD
Prednisolone—Oedema—Doxorubicin—urinary bladder cancer	0.000188	0.000762	CcSEcCtD
Prednisolone—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000186	0.00243	CbGpPWpGaD
Prednisolone—Pain—Methotrexate—urinary bladder cancer	0.000186	0.000753	CcSEcCtD
Prednisolone—Shock—Doxorubicin—urinary bladder cancer	0.000185	0.00075	CcSEcCtD
Prednisolone—Insomnia—Epirubicin—urinary bladder cancer	0.000184	0.000745	CcSEcCtD
Prednisolone—Tachycardia—Doxorubicin—urinary bladder cancer	0.000183	0.000744	CcSEcCtD
Prednisolone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000182	0.000739	CcSEcCtD
Prednisolone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000182	0.000737	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000181	0.00236	CbGpPWpGaD
Prednisolone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000179	0.000725	CcSEcCtD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000177	0.0023	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000176	0.0023	CbGpPWpGaD
Prednisolone—Pain—Epirubicin—urinary bladder cancer	0.000174	0.000704	CcSEcCtD
Prednisolone—CYP2A6—NRF2 pathway—GSTM1—urinary bladder cancer	0.000173	0.00226	CbGpPWpGaD
Prednisolone—Urticaria—Methotrexate—urinary bladder cancer	0.000172	0.000699	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000172	0.00224	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000172	0.00224	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000171	0.00223	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.00017	0.00222	CbGpPWpGaD
Prednisolone—Insomnia—Doxorubicin—urinary bladder cancer	0.00017	0.000689	CcSEcCtD
Prednisolone—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.00017	0.00221	CbGpPWpGaD
Prednisolone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000169	0.000684	CcSEcCtD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000168	0.00219	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000167	0.00218	CbGpPWpGaD
Prednisolone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000167	0.000679	CcSEcCtD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—urinary bladder cancer	0.000167	0.00217	CbGpPWpGaD
Prednisolone—CYP2A6—Biological oxidations—GSTP1—urinary bladder cancer	0.000165	0.00216	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000162	0.00212	CbGpPWpGaD
Prednisolone—Urticaria—Epirubicin—urinary bladder cancer	0.000161	0.000654	CcSEcCtD
Prednisolone—Pain—Doxorubicin—urinary bladder cancer	0.000161	0.000652	CcSEcCtD
Prednisolone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00016	0.000648	CcSEcCtD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—urinary bladder cancer	0.000159	0.00208	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000157	0.00204	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—SMC1A—urinary bladder cancer	0.000156	0.00204	CbGpPWpGaD
Prednisolone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000155	0.000628	CcSEcCtD
Prednisolone—CYP2A6—Biological oxidations—GSTM1—urinary bladder cancer	0.000152	0.00198	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000152	0.00198	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000151	0.00197	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—PPARG—urinary bladder cancer	0.000151	0.00197	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.00015	0.00196	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—urinary bladder cancer	0.00015	0.00196	CbGpPWpGaD
Prednisolone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00015	0.000607	CcSEcCtD
Prednisolone—Urticaria—Doxorubicin—urinary bladder cancer	0.000149	0.000605	CcSEcCtD
Prednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000146	0.00191	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—RB1—urinary bladder cancer	0.000145	0.00189	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000144	0.00188	CbGpPWpGaD
Prednisolone—Dizziness—Methotrexate—urinary bladder cancer	0.000143	0.000582	CcSEcCtD
Prednisolone—NR3C1—Adipogenesis—IGF1—urinary bladder cancer	0.000143	0.00187	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—EP300—urinary bladder cancer	0.000143	0.00186	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000141	0.00184	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GSTZ1—urinary bladder cancer	0.000141	0.00184	CbGpPWpGaD
Prednisolone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000138	0.000561	CcSEcCtD
Prednisolone—Progesterone—ESR1—urinary bladder cancer	0.000138	0.192	CrCbGaD
Prednisolone—Rash—Methotrexate—urinary bladder cancer	0.000137	0.000555	CcSEcCtD
Prednisolone—Dermatitis—Methotrexate—urinary bladder cancer	0.000137	0.000554	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—ESR2—urinary bladder cancer	0.000136	0.00178	CbGpPWpGaD
Prednisolone—Headache—Methotrexate—urinary bladder cancer	0.000136	0.000551	CcSEcCtD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000135	0.00176	CbGpPWpGaD
Prednisolone—Dizziness—Epirubicin—urinary bladder cancer	0.000134	0.000545	CcSEcCtD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000134	0.00175	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000134	0.00175	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GSTO2—urinary bladder cancer	0.000134	0.00174	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—NAT1—urinary bladder cancer	0.000134	0.00174	CbGpPWpGaD
Prednisolone—Triamcinolone—PTGS2—urinary bladder cancer	0.000132	0.184	CrCbGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000131	0.00171	CbGpPWpGaD
Prednisolone—Nausea—Methotrexate—urinary bladder cancer	0.000129	0.000523	CcSEcCtD
Prednisolone—Rash—Epirubicin—urinary bladder cancer	0.000128	0.000519	CcSEcCtD
Prednisolone—Dermatitis—Epirubicin—urinary bladder cancer	0.000128	0.000519	CcSEcCtD
Prednisolone—Headache—Epirubicin—urinary bladder cancer	0.000127	0.000516	CcSEcCtD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000126	0.00164	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000125	0.00164	CbGpPWpGaD
Prednisolone—Dizziness—Doxorubicin—urinary bladder cancer	0.000124	0.000504	CcSEcCtD
Prednisolone—SLCO1A2—Metabolism—UGT2B7—urinary bladder cancer	0.000122	0.00159	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000122	0.00159	CbGpPWpGaD
Prednisolone—Nausea—Epirubicin—urinary bladder cancer	0.000121	0.000489	CcSEcCtD
Prednisolone—Rash—Doxorubicin—urinary bladder cancer	0.000118	0.00048	CcSEcCtD
Prednisolone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000118	0.00048	CcSEcCtD
Prednisolone—Headache—Doxorubicin—urinary bladder cancer	0.000118	0.000477	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000116	0.00151	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000114	0.00148	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000113	0.00147	CbGpPWpGaD
Prednisolone—Nausea—Doxorubicin—urinary bladder cancer	0.000112	0.000453	CcSEcCtD
Prednisolone—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000111	0.00145	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP4B1—urinary bladder cancer	0.00011	0.00144	CbGpPWpGaD
Prednisolone—Betamethasone—PTGS2—urinary bladder cancer	0.000108	0.15	CrCbGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000108	0.00141	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NCOR1—urinary bladder cancer	0.000105	0.00137	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—SLC19A1—urinary bladder cancer	0.000104	0.00136	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—CDKN1A—urinary bladder cancer	0.000104	0.00136	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	0.000102	0.00133	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GSTZ1—urinary bladder cancer	0.000101	0.00132	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PRSS3—urinary bladder cancer	0.000101	0.00132	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000101	0.00132	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—ESR2—urinary bladder cancer	9.97e-05	0.0013	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	9.96e-05	0.0013	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—ERCC2—urinary bladder cancer	9.89e-05	0.00129	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GSTO2—urinary bladder cancer	9.61e-05	0.00125	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—NAT1—urinary bladder cancer	9.61e-05	0.00125	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	9.22e-05	0.0012	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	9.13e-05	0.00119	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	9.02e-05	0.00118	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—MYC—urinary bladder cancer	8.93e-05	0.00117	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	8.83e-05	0.00115	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	8.81e-05	0.00115	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—UGT2B7—urinary bladder cancer	8.79e-05	0.00115	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	8.75e-05	0.00114	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	8.57e-05	0.00112	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	8.54e-05	0.00111	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	8.42e-05	0.0011	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—ESR1—urinary bladder cancer	8.27e-05	0.00108	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.12e-05	0.00106	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—TYMP—urinary bladder cancer	8.09e-05	0.00106	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—TNF—urinary bladder cancer	8.02e-05	0.00105	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	7.91e-05	0.00103	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.77e-05	0.00101	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	7.69e-05	0.001	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—PPARG—urinary bladder cancer	7.54e-05	0.000984	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	7.47e-05	0.000975	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	7.46e-05	0.000973	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—NAT2—urinary bladder cancer	7.32e-05	0.000955	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	7.28e-05	0.00095	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—CREBBP—urinary bladder cancer	7.25e-05	0.000945	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.2e-05	0.000939	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	6.93e-05	0.000905	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	6.59e-05	0.00086	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	6.56e-05	0.000857	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	6.54e-05	0.000853	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	6.42e-05	0.000838	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	6.32e-05	0.000824	CbGpPWpGaD
Prednisolone—Dexamethasone—PTGS2—urinary bladder cancer	6.28e-05	0.0875	CrCbGaD
Prednisolone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.07e-05	0.000792	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	6.04e-05	0.000789	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	6.03e-05	0.000787	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.98e-05	0.000781	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	5.85e-05	0.000764	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	5.85e-05	0.000764	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—TYMP—urinary bladder cancer	5.82e-05	0.00076	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.82e-05	0.000759	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.73e-05	0.000748	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GSTO2—urinary bladder cancer	5.72e-05	0.000746	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—NAT1—urinary bladder cancer	5.72e-05	0.000746	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	5.68e-05	0.000741	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.66e-05	0.000738	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.59e-05	0.000729	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.58e-05	0.000728	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	5.51e-05	0.00072	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	5.51e-05	0.000718	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.5e-05	0.000718	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.31e-05	0.000693	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	5.3e-05	0.000691	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—NAT2—urinary bladder cancer	5.27e-05	0.000687	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	5.23e-05	0.000683	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.86e-05	0.000634	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—ESR2—urinary bladder cancer	4.8e-05	0.000626	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.8e-05	0.000626	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	4.72e-05	0.000615	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	4.71e-05	0.000615	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.69e-05	0.000612	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.58e-05	0.000597	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—RRM2—urinary bladder cancer	4.55e-05	0.000593	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	4.45e-05	0.00058	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PRSS3—urinary bladder cancer	4.33e-05	0.000566	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—MYC—urinary bladder cancer	4.3e-05	0.000561	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.24e-05	0.000553	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ENO2—urinary bladder cancer	4.21e-05	0.000549	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	4.21e-05	0.000549	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.1e-05	0.000535	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.09e-05	0.000534	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	4.08e-05	0.000533	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.99e-05	0.000521	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	3.93e-05	0.000513	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.9e-05	0.000509	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.81e-05	0.000497	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.79e-05	0.000495	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.72e-05	0.000485	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	3.7e-05	0.000483	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	3.66e-05	0.000477	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	3.62e-05	0.000472	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	3.62e-05	0.000472	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.52e-05	0.00046	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.52e-05	0.00046	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	3.48e-05	0.000455	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.46e-05	0.000452	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	3.46e-05	0.000452	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.4e-05	0.000444	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	3.4e-05	0.000444	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—NQO1—urinary bladder cancer	3.39e-05	0.000443	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.33e-05	0.000434	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.22e-05	0.000421	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	3.19e-05	0.000417	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.17e-05	0.000413	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	3.14e-05	0.00041	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.14e-05	0.00041	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.13e-05	0.000409	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—ESR1—urinary bladder cancer	2.91e-05	0.00038	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.9e-05	0.000379	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	2.83e-05	0.000369	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.79e-05	0.000364	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.74e-05	0.000358	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.7e-05	0.000353	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.67e-05	0.000348	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PPARG—urinary bladder cancer	2.66e-05	0.000346	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—TYMS—urinary bladder cancer	2.63e-05	0.000343	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	2.6e-05	0.000339	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	2.6e-05	0.000339	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	2.59e-05	0.000338	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	2.55e-05	0.000333	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.51e-05	0.000327	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.51e-05	0.000327	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GPX1—urinary bladder cancer	2.49e-05	0.000325	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	2.49e-05	0.000325	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	2.45e-05	0.000319	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.43e-05	0.000317	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	2.3e-05	0.0003	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.27e-05	0.000297	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.13e-05	0.000279	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	2.04e-05	0.000266	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.02e-05	0.000263	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.93e-05	0.000252	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PPARG—urinary bladder cancer	1.86e-05	0.000243	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	1.79e-05	0.000234	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.78e-05	0.000232	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.7e-05	0.000221	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.68e-05	0.00022	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.67e-05	0.000217	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.57e-05	0.000204	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.55e-05	0.000202	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.55e-05	0.000202	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.54e-05	0.000201	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.54e-05	0.000201	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—MYC—urinary bladder cancer	1.51e-05	0.000198	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.5e-05	0.000195	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.48e-05	0.000193	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	1.47e-05	0.000191	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.46e-05	0.00019	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.37e-05	0.000178	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTEN—urinary bladder cancer	1.28e-05	0.000167	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.24e-05	0.000162	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—EP300—urinary bladder cancer	1.22e-05	0.000159	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.11e-05	0.000145	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.07e-05	0.000139	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.04e-05	0.000135	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.65e-06	0.000126	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.53e-06	0.000124	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.53e-06	0.000124	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.13e-06	0.000119	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.96e-06	0.000117	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTGS2—urinary bladder cancer	8.72e-06	0.000114	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.43e-06	0.00011	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTEN—urinary bladder cancer	7.61e-06	9.93e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—EP300—urinary bladder cancer	7.26e-06	9.47e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.83e-06	8.92e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.56e-06	8.57e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.38e-06	7.01e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.69e-06	6.12e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.47e-06	5.83e-05	CbGpPWpGaD
